Find clinical trials for Eczema in St Louis, MO

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Atopic Dermatitis

Dermatitis

Pruritus

Skin Diseases

Immune System Diseases

Eczematous Skin Diseases

Food Hypersensitivity

Eczema trials near St Louis, MO, USA:

Locations recently updated

A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema

This research study is being conducted to find out if the test medicine, abrocitinib, improves eczema and is safe for children 6 to \<12 yea...

Enrolling

Eczema

Drug: Abrocitinib

Other: Placebo

Phase 3

Pfizer

St Louis, Missouri, United States and 42 other locations

Locations recently updated

A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

This 24-month study will assess the long-term safety and efficacy of liquid abrocitinib oral suspension with or without topical medications in childr...

Enrolling

Atopic Dermatitis

Drug: Abrocitinib

Phase 3

Pfizer

St Louis, Missouri, United States and 37 other locations

Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to <18 Years of Age With Atopic Dermatitis (AD)

The primary objective of the study is to assess the long-term safety of dupilumab in pediatric participants with AD.The secondary objectives of the s...

Active, not recruiting

Atopic Dermatitis

Drug: Dupilumab

Phase 3